Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Moodys
Medtronic
Colorcon
Boehringer Ingelheim

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

HERCEPTIN Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for HERCEPTIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
xuexin hePhase 2
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
First Affiliated Hospital, Sun Yat-Sen UniversityPhase 2

See all HERCEPTIN clinical trials

Recent Litigation for HERCEPTIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29

See all HERCEPTIN litigation

PTAB Litigation
PetitionerDate
2018-01-08
Pfizer, Inc.2017-06-30
2017-03-10

See all HERCEPTIN litigation

Pharmacology for HERCEPTIN
Mechanism of ActionHER2/Neu/cerbB2 Antagonists

Patent Text Search: US Patents for HERCEPTIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for HERCEPTIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
132016000070123 Italy   Start Trial PRODUCT NAME: RITUXIMAB IN ASSOCIAZIONE CON IALURONIDASI RICOMBINANTE UMANA - SOLUZIONE PER INIEZIONE SOTTOCUTANEA(MABTHERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/98/067/001-003, 20140326
122017000015 Germany   Start Trial PRODUCT NAME: IBRUTINIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/14/945-C(2015)4704 20150703
CA 2015 00043 Denmark   Start Trial PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826
300868 Netherlands   Start Trial PRODUCT NAME: IBRUTINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/14/945 - C(2015)4704 20150707
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Express Scripts
Merck
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.